フロリダ州におけるけいれん発作の臨床試験
フロリダ州内の拠点で、けいれん発作に関する16件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Northwest Florida Clinical Research Group, LLC, Gulf Breeze
- Ilumina Medical Research, Kissimmee
- Visionary Investigators Network, Miami
- 他3件
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/10/01更新 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Panhandle Research and Medical Clinic, LLC, Gulf Breeze
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07563881Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
- Mayo Clinic, Jacksonville
被験者募集中早期第1相参加者への支払いあり
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07012148Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- University of Florida, Gainesville
被験者募集中
50歳以下 · 全性別 · 2026/09/17更新 · NCT02216500A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Pediatric Neurology and Epilepsy Specialists, Winter Park
被験者募集中第3相
2歳以上 · 全性別 · 2026/09/15更新 · NCT04462770An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- University of Miami Miller School of Medicine, Miami
- AdventHealth Innovation Tower, Orlando
被験者募集中第3相
2歳〜55歳 · 全性別 · 2026/09/15更新 · NCT05066217Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- K2 Medical Research, Maitland
- Serenity Research Center, LLC, Miami
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/02更新 · NCT07594119A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- University of South Florida, Tampa
被験者募集中第1相
12歳〜75歳 · 全性別 · 2026/08/11更新 · NCT07233239Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Miami, Miami
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/06/09更新 · NCT05135091AI-Based Mobile Intervention on Medication Non-Adherence and Transition
- Orlando Health Arnold Palmer Hospital, Orlando
- Orlando Health Orlando Regional Medical Center, Orlando
被験者募集中
14歳〜24歳 · 全性別 · 2026/05/29更新 · NCT07445074A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Panhandle Research and Medical Clinic, Gulf Breeze
- Mayo Clinic Florida, Jacksonville
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/14更新 · NCT05716100Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
- Green Leaf Clinical Trials, LLC, Jacksonville
- Visionary Investigators Network, Miami
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/04/21更新 · NCT05518578Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Miami VA Healthcare System, Miami, FL, Miami
被験者募集中第4相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/20更新 · NCT04419272SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
- Medsol Clinical Research Center, Port Charlotte
被験者募集中第2相
18歳以上 · 全性別 · 2025/10/10更新 · NCT07141329Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Pediatric Epilepsy and Neurology Specialists, Tampa
被験者募集中第3相
4歳〜55歳 · 全性別 · 2025/07/24更新 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Miami Lakes
被験者募集中第2相
18歳〜75歳 · 全性別 · 2025/04/03更新 · NCT06908356ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。